CervoMed CRVO Income Statement (2010-2026)

NASDAQ CRVO
$2.88 +0.21 (+7.87%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

CervoMed Quarterly Income Statement

Periods 64 quarters
Latest Jun 2026

CervoMed reported net income of -$6.57M for the quarter ended Jun 2026. This income statement covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.36M1.36M1.36M1.36M0.52M1.36M1.36M3.31M2.66M5.34M8.70M8.70M8.70M8.70M9.25M9.25M9.25M9.26M10.24M
Revenue & cost
Revenue
1.41M1.72M1.53M2.49M2.35M3.29M1.94M2.16M1.92M1.76M0.32M0.01M
Gross Profit
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.02M0.03M
Research & DevelopmentR&D
2.11M1.50M2.43M2.11M0.33M0.38M1.83M1.96M1.79M2.86M2.81M3.77M5.13M7.09M4.84M5.11M6.04M5.83M5.14M4.32M
Selling, General & AdministrativeSG&A
1.93M1.93M2.13M2.14M0.57M0.56M1.00M0.99M2.41M2.12M2.13M2.51M2.21M2.32M2.38M3.27M2.33M2.51M2.98M2.36M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
0.07M0.11M0.08M0.11M0.11M0.18M0.12M0.12M
Operating ExpensesOpex
4.05M3.47M4.55M4.25M0.90M0.94M2.83M2.95M4.20M4.97M4.94M6.28M7.34M9.40M7.22M8.37M8.37M8.34M8.11M6.68M
Operating IncomeOp. Inc
-12.69M-3.47M-4.55M-4.25M-0.90M-0.94M-1.43M-1.23M-2.68M-2.48M-2.59M-3.00M-5.40M-7.24M-5.30M-6.62M-8.04M-8.33M-8.11M-6.68M
EBIT
-12.69M-3.47M-4.55M-4.25M-0.90M-0.94M-1.43M-1.23M-2.68M-2.48M-2.59M-3.00M-5.40M-7.24M-5.30M-6.62M-8.04M-8.33M-8.11M-6.68M
Non-operating items
Non Operating Interest Expenses
Goodwill impairment chargesGoodwill Impair.
Interest & Investment IncomeInt & Inv Inc
0.02M0.03M0.04M0.02M0.05M0.12M0.08M0.68M0.65M0.53M0.41M0.37M0.32M0.24M0.15M0.10M
Other Non Operating IncomeOther Non Op Inc.
-88.00-0.62M0.86M-0.21M4.78M-600.00-30.00-247.00-0.00M0.00M-135.00-0.01M-0.00M0.00M-0.00M0.00M
Non Operating IncomeNon Op. Inc.
0.02M-0.59M0.89M-0.19M4.83M0.12M0.08M0.68M0.64M0.53M0.41M0.36M0.32M0.24M0.15M0.11M
Net income details
EBT
-12.64M-3.47M-4.55M-4.25M-2.80M-4.08M-1.39M-1.21M-2.63M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.25M-7.73M-8.09M-7.96M-6.57M
Tax ProvisionsTaxes
-0.44M-0.40M
Profit After TaxPAT
-12.20M-3.07M-4.55M-4.25M-2.80M-4.08M-1.39M-1.21M-2.63M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.25M-7.73M-8.09M-7.96M-6.57M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
-12.20M-3.07M-4.55M-4.25M-2.80M-4.08M-1.39M-1.21M-2.63M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.25M-7.73M-8.09M-7.96M-6.57M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
-12.20M-3.07M-4.55M-4.25M-2.80M-4.08M-1.39M-1.21M-2.63M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.25M-7.73M-8.09M-7.96M-6.57M
Income towards Parent CompanyParent Net Inc
-12.20M-3.47M-4.53M-4.19M-0.88M-1.53M-0.53M-1.43M2.15M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.26M-7.73M-8.09M-7.96M-6.57M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-12.20M-3.47M-4.53M-4.19M-0.88M-1.53M-0.53M-1.43M-2.63M-2.36M-2.51M-2.32M-4.75M-6.71M-4.89M-6.26M-7.73M-8.09M-7.96M-6.57M
Additional items
EPS (Basic)
-8.98-2.56-3.33-3.08-0.65-2.95-0.39-1.05-0.79-0.89-0.41-0.27-0.55-0.83-0.56-0.70-0.84-0.89-0.86-0.64
EPS (Diluted)
-5.64-1.61-2.09-1.94-1.70-2.95-1.03-2.75-0.70-0.63-0.67-0.62-0.55-0.77-0.56-0.72-0.89-0.93-0.92-0.76
Shares Outstanding
1.36M1.36M1.36M1.36M1.36M0.52M1.36M1.36M3.31M2.66M6.17M8.70M8.70M8.07M8.70M8.95M9.25M9.04M9.26M10.24M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.16M2.16M2.16M2.16M0.52M0.52M0.52M0.52M3.77M3.77M3.77M3.77M8.70M8.70M8.70M8.70M8.70M8.70M8.70M8.70M
EBITDA
-12.67M-4.55M-4.25M-0.90M
Interest ExpensesInt Expense

CervoMed Income Statement API

Pull CervoMed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRVO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY